Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer.

Parsons BM, Meier DR, Richmond CS, Gurda GT, Lofgren KA, Burkard ME, Deming DA, Kenny PA
Clin Breast Cancer. 2020 Aug;20(4):e433-e438. doi: 10.1016/j.clbc.2020.02.003. Epub 2020 Feb 19. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.